Total population (n=447) |
HPV type |
+/+ |
+/- |
-/+ |
-/- |
Agreement [%] |
Kappa [95% CI] |
|
hrHPV |
212 |
38 |
27 |
170 |
85.5 |
0.707 (0.641 -
0.773) |
|
HPV16 |
56 |
10 |
6 |
375 |
96.4 |
0.854 (0.784 -
0.924) |
|
HPV18 |
11 |
3 |
3 |
430 |
98.7 |
0.779 (0.607 - 0.951) |
|
Other hrHPV |
156 |
38 |
35 |
218 |
83.6 |
0.667 (0.597 -
0.737) |
≥CIN2
(n=106)
|
HPV type
|
+/+
|
+/-
|
-/+
|
-/-
|
Agreement [%]
|
Kappa [95% CI]
|
|
hrHPV |
84 |
8 |
3 |
11 |
89.6 |
0.607 (0.398 - 0.816) |
|
HPV16 |
31 |
6 |
5 |
64 |
89.6 |
0.770 (0.642 - 0.898) |
|
HPV18 |
2 |
1 |
1 |
102 |
98.1 |
0.657 (0.212 - 1.000) |
|
Other hrHPV |
56 |
10 |
5 |
35 |
85.9 |
0.706 (0.569 -
0.843) |
<CIN2 (n=342) |
HPV type |
+/+ |
+/- |
-/+ |
-/- |
Agreement [%] |
Kappa [95% CI] |
|
hrHPV |
128 |
30 |
24 |
159 |
84.2 |
0.681 (0.603 -
0.759) |
|
HPV16 |
25 |
4 |
1 |
311 |
98.5 |
0.901 (0.816 - 0.987) |
|
HPV18 |
9 |
2 |
2 |
328 |
98.8 |
0.812 (0.632 - 0.992) |
|
Other hrHPV |
100 |
28 |
30 |
183 |
83.0 |
0.638 (0.554 -
0.723) |